---
title: "DYAI.US (DYAI.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DYAI.US/news.md"
symbol: "DYAI.US"
name: "DYAI.US"
parent: "https://longbridge.com/en/quote/DYAI.US.md"
datetime: "2026-03-07T03:21:43.774Z"
locales:
  - [en](https://longbridge.com/en/quote/DYAI.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DYAI.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DYAI.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/DYAI.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/DYAI.US/news.md)


# DYAI.US (DYAI.US) — Related News

### [Dyadic International Launches $4.24 Million ATM Equity Program With Craig-Hallum](https://longbridge.com/en/news/278175038.md)
*2026-03-06T22:13:00.000Z*
> Dyadic International has launched a $4.24 million At-The-Market equity program with Craig-Hallum Capital Group. The agre

### [Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone | DYAI Stock News](https://longbridge.com/en/news/277462399.md)
*2026-03-02T04:20:00.000Z*
> Dyadic Applied BioSolutions and Inzymes ApS announced the planned commercialization of a non-animal dairy enzyme, recomb

### [Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin | DYAI Stock News](https://longbridge.com/en/news/276123120.md)
*2026-02-17T04:25:00.000Z*
> Dyadic Applied BioSolutions and Proliant Health & Biologicals have launched AlbuFree™ DX, a recombinant human albumin pr

### [Dyadic International Extends Convertible Note Maturity and Sets New Conversion Price](https://longbridge.com/en/news/271029313.md)
*2025-12-29T21:01:24.000Z*
> Dyadic International Inc. has announced an extension of the maturity date for its convertible notes to the end of 2027 a

### [Dyadic International Disclosed Failure to Satisfy a Continued Listing Rule or Standard](https://longbridge.com/en/news/270985948.md)
*2025-12-29T11:03:00.000Z*
> Dyadic International has disclosed that it failed to meet Nasdaq's continued listing requirement of maintaining a minimu

### [Dyadic and Fermbox Bio collaborate to commercialize animal-free proteins/enzymes in various markets.](https://longbridge.com/en/news/270012007.md)
*2025-12-17T12:21:30.000Z*
> Dyadic and Fermbox Bio have decided to enhance their strategic partnership with the aim of expediting the production of